Clearside Biomedical, Inc. — Director's Dealing 2024

Mar 18, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Clearside Biomedical, Inc. (CLSD)
CIK: 0001539029
Period of Report: 2024-03-18

Reporting Person: Chong Ngai Hang Victor (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-03-18	Employee Stock Option (right to buy)	$1.56	A	450000	Acquired	2034-03-18	Common Stock (450000)	Direct

Footnotes

F1: One-fourth of the shares underlying this option vest on March 18, 2025 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.